Vaccines against Herpes zoster: Effectiveness, safety, and cost/benefit ratio

A vaccination against herpes zoster and its complication is available in France since June 2015. Its exact benefit for public health is still controversial and its level of protection is not optimal. All those reasons seem to suggest a low acceptation rate from general practitioners. To evaluate the...

Full description

Saved in:
Bibliographic Details
Published inLa Presse médicale (1983) Vol. 45; no. 2; p. 162
Main Authors Ferahta, Nabila, Achek, Imene, Dubourg, Julie, Lang, Pierre-Olivier
Format Journal Article
LanguageFrench
Published France 01.02.2016
Subjects
Online AccessGet full text

Cover

Loading…